GriffiithR. S.BlackH. R.: Cephalexin, Med. Clin. N. Am.54: 1229–1244 (Sept.) 1970.
2.
ChouT. S.: Isolation and Identification of Cephalexin from Human Urine, J. Med. Chem.12: 925, 1969.
3.
GowerP. E.DashC. H.: Cephalexin: Human Studies of Absorption and Excretion of a New Cephalosporin Antibiotic, Brit. J. Pharmacol.37: 738, 1969.
4.
MeyersB. R.KaplanK.WeinsteinL.: Cephalexin: Microbiological Effects and Pharmacologic Parameters in Man, Clin. Pharmacol. Therap.10: 810 (Nov.-Dec.) 1969.
5.
HuantN.: Personal communication with Lilly Co.
6.
KuninC. M.FinkelbergZ.: Oral Cephalexin and Ampicillin: Antimicrobial Activity, Recovery in Urine, and Persistence in Uremic Patients, Ann. Internal Med.72: 349–356 (Mar.) 1970.
7.
ThornhillT. S.: In Vitro Antimicrobial Activity and Human Pharmacology of Cephalexin, a New Orally Absorbed Cephalosporin C Antibiotic, Appl. Microbiol.17: 457–461 (Mar.) 1969.
8.
LinquistJ. A.: Cephalexin in Patients with Renal Disease, New Engl. J. Med.283: 720–723 (Oct. 1) 1970.
9.
Manufacturer's Prerelease Review of Clinical and Laboratory Data.
10.
AcarJ. F.: Clinical and Laboratory Evaluation of Cephalexin in Urinary Tract Infections, Antimicrobial Agents Chemotherapy, 1969, pp. 398–404.
11.
PageJ.: Treatment of Soft-Tissue Infection with Cephalexin, J. Am. Med. Assoc.211: 1837–1839 (Mar. 16) 1970.
12.
StratfordB. C.: Clinical Experience with Cephalexin, Med. J. Australia2: 73–77 (July 11) 1970.